Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone vs Remifentanil for analgesia in mechanically ventilated patients
NCT06444997Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jun 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of oxycodone in pain (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Percentage of time with Critical care Pain Observation Tool (CPOT) < 3 without rescue analgesia at 7 days. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
pain
Beyond the preview
Go deeper on NCT06444997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06444997.